2025. Real-world Effectiveness of Tralokinumab in Adults with Atopic Dermatitis: Interim Data on Improvements in Patients with Head and Neck Atopic Dermatitis after up to 9 Months of Treatment in the TRACE Study. SKIN The Journal of Cutaneous Medicine. 9, 2 (Mar. 2025), s574. DOI:https://doi.org/10.25251/skin.10.supp.574.